ES2069298T3 - Secuencias no-a no-b. - Google Patents

Secuencias no-a no-b.

Info

Publication number
ES2069298T3
ES2069298T3 ES91911014T ES91911014T ES2069298T3 ES 2069298 T3 ES2069298 T3 ES 2069298T3 ES 91911014 T ES91911014 T ES 91911014T ES 91911014 T ES91911014 T ES 91911014T ES 2069298 T3 ES2069298 T3 ES 2069298T3
Authority
ES
Spain
Prior art keywords
nanbh
detection
refers
sequences
pestide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91911014T
Other languages
English (en)
Inventor
Jan Albert Hellings
Haard Johannes Josef Wilhel De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2069298T3 publication Critical patent/ES2069298T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A UNA SECUENCIA DE ACIDOS NUCLEICOS QUE AL MENOS EN PARTE ES UNA CODIFICACION PARA UN PECTIDO DE VIRUS DE HEPATITIS NO A, NO B (NANBH) O UN FRAGMENTO DEL MISMO. TAMBIEN SE REFIERE A UN METODO PARA LA DETECCION DE NANBH O ANTI NBANBH EN UN FLUIDO DE PRUEBA Y TAMBIEN A UN REACTIVO INMUNOQUIMICO Y UN EQUIPO DE PRUEBA A UTILIZARSE CUANDO SE APLICAN DICHOS METODOS DE DETECCION.
ES91911014T 1990-06-30 1991-06-14 Secuencias no-a no-b. Expired - Lifetime ES2069298T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90201746 1990-06-30

Publications (1)

Publication Number Publication Date
ES2069298T3 true ES2069298T3 (es) 1995-05-01

Family

ID=8205048

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91911014T Expired - Lifetime ES2069298T3 (es) 1990-06-30 1991-06-14 Secuencias no-a no-b.

Country Status (14)

Country Link
US (1) US5620843A (es)
EP (1) EP0551275B1 (es)
JP (1) JPH05508318A (es)
AT (1) ATE115964T1 (es)
AU (2) AU7967191A (es)
CA (1) CA2072092A1 (es)
DE (1) DE69106141T2 (es)
DK (1) DK0551275T3 (es)
ES (1) ES2069298T3 (es)
FI (1) FI923020A0 (es)
GR (1) GR3015437T3 (es)
IE (1) IE64571B1 (es)
WO (1) WO1992000328A1 (es)
ZA (1) ZA914682B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
ZA95797B (en) 1994-02-14 1996-06-20 Qualcomm Inc Dynamic sectorization in a spread spectrum communication system
US7235394B1 (en) 1995-08-29 2007-06-26 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US7049428B1 (en) * 1998-03-04 2006-05-23 Washington University HCV variants
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
US6586584B2 (en) 2001-01-29 2003-07-01 Becton, Dickinson And Company Sequences and methods for detection of Hepatitis C virus
CN101107081A (zh) * 2004-10-19 2008-01-16 麻省理工学院 晶体缺陷的生物分子识别

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744242A1 (de) * 1987-02-20 1989-07-06 Seelig Renate Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
HU216017B (hu) * 1987-11-18 1999-04-28 Chiron Corp. Eljárás HCV-1 polipeptidek, HCV-1 polinukleotidok, rekombináns vektorok és gazdasejtek, valamint immunesszé kit, hepatitis C vírusfertőzés elleni vakcinák, a fertőzés kimutatására szolgáló diagnosztikumok előállítására, és immunvizsgálati és vírustenyészt
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
HU225068B1 (en) * 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
RO113059B1 (ro) * 1989-05-18 1998-03-30 Chiron Corp Polinucleotida capabila de hibridizare pe o secventa hcv, metoda pentru detectarea unei secvente hcv si procedeu de eliminare a hcv din sange

Also Published As

Publication number Publication date
EP0551275B1 (en) 1994-12-21
CA2072092A1 (en) 1991-12-31
FI923020A (fi) 1992-06-29
DE69106141D1 (de) 1995-02-02
IE64571B1 (en) 1995-08-23
EP0551275A1 (en) 1993-07-21
GR3015437T3 (en) 1995-06-30
IE912090A1 (en) 1992-01-01
ATE115964T1 (de) 1995-01-15
DK0551275T3 (da) 1995-05-29
US5620843A (en) 1997-04-15
AU7967191A (en) 1992-01-23
WO1992000328A1 (en) 1992-01-09
JPH05508318A (ja) 1993-11-25
ZA914682B (en) 1992-04-29
DE69106141T2 (de) 1995-05-24
AU8156594A (en) 1995-03-09
FI923020A0 (fi) 1992-06-29

Similar Documents

Publication Publication Date Title
DE69839557D1 (de) Klonierte genome von infektiösen hepatitis c viren und deren verwendungen
ATE247174T1 (de) Verfahren zum besonders sensitiven nachweis von nukleinsäuren
DE69329108D1 (de) Verfahren zur inaktivierung von viren
ATE281647T1 (de) Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien
DK0637342T3 (da) Fremgangsmåde til typebestemmelse af HCV-isolater
BR7908410A (pt) Meio para deteccao de anticorpos de vhb no soro do sangue,e processo para deteccao da presenca da infeccao por virus da hepatite b em seres humanos
BE1002134A5 (fr) Avipox virus recombinant.
ES2101388T3 (es) Antigenos sinteticos para la deteccion de anticuerpos para el virus de la hepatitis c.
ES2069298T3 (es) Secuencias no-a no-b.
DK0649904T3 (da) Diagnostisk reagens til påvisning af antistoffer mod EBV
DK0552829T3 (da) CENP-B-peptid
MX9205203A (es) Sonda que incluye acidos nucleicos para la deteccion de virus de arn de la hepatitis c
ES2070415T3 (es) Peptidos inmunoquimicamente reactivos con anticuerpos dirigidos contra el virus de la hepatitis no-a, no-b.
ES2066547T3 (es) Peptidos, inmunoquimicamente reactivos con anticuerpos dirigidos contra virus de hepatitis no-a, no-b.
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
ES2156858T3 (es) Reactivo de diagnostico para hepatitis c.
DK192890D0 (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
Smith Detection methods for rodent viruses.
FI952778A (fi) Hepatiitti-C-viruksen (HCV) 3-ei-rakenne-peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 551275

Country of ref document: ES